Overview
Status
Active
Registry date
2015-05-08
Share capital
5,000.00 PLN
Registered address
Aleja Komisji Edukacji Narodowej 36/112b, 02-797 Warszawa, Poland
Email
Financials
Total Operating Costs
787.87k
+22.9% vs 2018
Revenue history (in k)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 1 of 5 financial statements was filed late (for 2022, 277 days late), 3 not filed.
- 2023not filed
- 202217/04/2024
- 2021not filed
- 2020not filed
- 2019not filed
- 201810/07/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2022.
Results vs industry
Revenue
This companyUSD 824.81kMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD 33.62kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 787.87kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 83.08kMedianUSD 883.09kAverageUSD 31.39m
Industry
Authorized Representatives
Kostiantyn Tkachenko – President of the Management Board
Manner of representation
Each member of the management board represents the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Robert Sebastian Seweryniakage 50 | 10 | $135.06 | 10% |
Kostiantyn Tkachenkoage 34 | 90 | $1,215.56 | 90% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2024-05-01 to 2024-11-07.
Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)
Debt
2 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| May 28, 2026 | Discontinued enforcement proceedings | Closed | |
| May 28, 2026 | Discontinued enforcement proceedings | Closed |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 17, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2018-03-27 | Address change (Ul. Adama Branickiego 21/78, 02-972, Warszawa → Aleja Komisji Edukacji Narodowej 36/112b, 02-797, Warszawa) | |
| 2017-11-13 | Address change (Ul. Wiertnicza 76, 02-952, Warszawa → Ul. Adama Branickiego 21/78, 02-972, Warszawa) | |
| 2015-09-24 | Address change (Ul. Wiertnicza 169, 02-952, Warszawa → Ul. Wiertnicza 76, 02-952, Warszawa) | |
| 2015-09-24 | Name change (Mkp Inwestycje → Medisfarm) | |
| 2015-09-24 | PKD change (Removed: 9 codes; Added: 10 codes) |
FAQ
The main business activity of Medisfarm focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on May 8, 2015.
The headquarters is located at: Aleja Komisji Edukacji Narodowej 36, 02-797 Warszawa.
The management board consists of: Kostiantyn Tkachenko (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
Last updated: 2026-04-11